Page last updated: 2024-09-05
l 659066 and mk 912
l 659066 has been researched along with mk 912 in 2 studies
Compound Research Comparison
Studies (l 659066) | Trials (l 659066) | Recent Studies (post-2010) (l 659066) | Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) |
---|---|---|---|---|---|
79 | 40 | 57 | 60 | 3 | 2 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Clineschmidt, BV; Hucker, HB; Huff, JR; Lis, EV; Lotti, VJ; Pettibone, DJ; Reiss, DR; Sweeney, BM; Vacca, J | 1 |
Campbell, WR; Potter, DE | 1 |
Other Studies
2 other study(ies) available for l 659066 and mk 912
Article | Year |
---|---|
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood-Brain Barrier; Callitrichinae; Clonidine; Decerebrate State; Dihydroxyphenylalanine; Gastrointestinal Motility; Male; Muscle Contraction; Quinolizines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vas Deferens; Yohimbine | 1988 |
The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Intraocular Pressure; Male; Pupil; Quinolizines; Rabbits | 1994 |